{"entity": "publication", "iuid": "81e02282dce74f98b8458cd248f99c32", "timestamp": "2026-11-18T14:26:19.758Z", "links": {"self": {"href": "https://publications.scilifelab.se/publication/81e02282dce74f98b8458cd248f99c32.json"}, "display": {"href": "https://publications.scilifelab.se/publication/81e02282dce74f98b8458cd248f99c32"}}, "title": "Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4-dihydroxybensoic acid.", "authors": [{"family": "Freyer", "given": "Christoph", "initials": "C"}, {"family": "Stranneheim", "given": "Henrik", "initials": "H"}, {"family": "Naess", "given": "Karin", "initials": "K"}, {"family": "Mourier", "given": "Arnaud", "initials": "A"}, {"family": "Felser", "given": "Andrea", "initials": "A"}, {"family": "Maffezzini", "given": "Camilla", "initials": "C"}, {"family": "Lesko", "given": "Nicole", "initials": "N"}, {"family": "Bruhn", "given": "Helene", "initials": "H"}, {"family": "Engvall", "given": "Martin", "initials": "M"}, {"family": "Wibom", "given": "Rolf", "initials": "R"}, {"family": "Barbaro", "given": "Michela", "initials": "M"}, {"family": "Hinze", "given": "Yvonne", "initials": "Y"}, {"family": "Magnusson", "given": "M\u00e5ns", "initials": "M"}, {"family": "Andeer", "given": "Robin", "initials": "R"}, {"family": "Zetterstr\u00f6m", "given": "Rolf H", "initials": "RH"}, {"family": "von D\u00f6beln", "given": "Ulrika", "initials": "U"}, {"family": "Wredenberg", "given": "Anna", "initials": "A"}, {"family": "Wedell", "given": "Anna", "initials": "A"}], "type": "case reports", "published": "2015-11-00", "journal": {"volume": "52", "issn": "1468-6244", "issue": "11", "pages": "779-783", "title": "J. Med. Genet.", "issn-l": "0022-2593"}, "abstract": "Coenzyme Q is an essential mitochondrial electron carrier, redox cofactor and a potent antioxidant in the majority of cellular membranes. Coenzyme Q deficiency has been associated with a range of metabolic diseases, as well as with some drug treatments and ageing.\n\nWe used whole exome sequencing (WES) to investigate patients with inherited metabolic diseases and applied a novel ultra-pressure liquid chromatography-mass spectrometry approach to measure coenzyme Q in patient samples.\n\nWe identified a homozygous missense mutation in the COQ7 gene in a patient with complex mitochondrial deficiency, resulting in severely reduced coenzyme Q levels We demonstrate that the coenzyme Q analogue 2,4-dihydroxybensoic acid (2,4DHB) was able to specifically bypass the COQ7 deficiency, increase cellular coenzyme Q levels and rescue the biochemical defect in patient fibroblasts.\n\nWe report the first patient with primary coenzyme Q deficiency due to a homozygous COQ7 mutation and a potentially beneficial treatment using 2,4DHB.", "doi": "10.1136/jmedgenet-2015-102986", "pmid": "26084283", "labels": {"National Genomics Infrastructure": null, "NGI Stockholm (Genomics Applications)": null, "NGI Stockholm (Genomics Production)": null, "Clinical Genomics Stockholm": null, "Clinical Genomics": null}, "xrefs": [{"db": "pii", "key": "jmedgenet-2015-102986"}, {"db": "pmc", "key": "PMC4680133"}], "notes": [], "created": "2017-05-02T12:57:02.012Z", "modified": "2020-01-21T13:56:03.375Z"}